2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow ACT-451840: new trials by email Literature Review of ACT-451840 trials Research Report on ACT-451840
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects ACT-451840:, Plasmodium falciparum-infected human erythrocytes:, Artemether 20 mg and lumefantrine 120mg combination tablet: - Healthy Subjects | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 8 | 2014-06-01 | 2019-08-22 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A) ACT-451840 10 mg, ACT-451840 50 mg, ACT-451840 200 mg - Healthy | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 40 | 2011-12-01 | 2019-08-09 |
Malaria (1)
Idorsia Pharmaceuticals Ltd. (2)
Australia (1) · France (1)
Michelle Lee (1)